Location History:
- San Francisco, CA (US) (2020)
- Vienna, AT (2021 - 2024)
Company Filing History:
4 out of 151 
2 out of 1,179 
Years Active: 2020-2024
Title: Bettina Ploder: Innovator in Medical Treatments
Introduction
Bettina Ploder is a distinguished inventor based in Vienna, Austria. She has made significant contributions to the field of medical treatments, particularly in addressing severe von Willebrand disease. With a total of 4 patents to her name, her work has the potential to improve patient outcomes in critical health situations.
Latest Patents
One of her latest patents focuses on the treatment of gastrointestinal bleeding in patients with severe von Willebrand disease. The invention involves administering recombinant von Willebrand Factor (rVWF) at doses ranging from about 40 IU/kg to about 100 IU/kg. This method also includes the administration of recombinant Factor VIII (rFVIII) in the first dose, showcasing her innovative approach to complex medical challenges.
Career Highlights
Bettina has worked with notable companies in the pharmaceutical industry, including Baxalta GmbH and Takeda Pharmaceutical Company Limited. Her experience in these organizations has allowed her to develop and refine her inventions, contributing to advancements in medical treatments.
Collaborations
Throughout her career, Bettina has collaborated with esteemed colleagues such as Miranda Chapman and Bruce Ewenstein. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in healthcare.
Conclusion
Bettina Ploder's contributions to medical innovation, particularly in treating severe von Willebrand disease, highlight her role as a leading inventor in the field. Her patents and collaborations reflect her commitment to improving patient care through innovative treatments.